U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433855) titled 'Efficacy and Safety of Heat-Treated Lactiplantibacillus Plantarum LM1004 on Immune Function' on Feb. 19.
Brief Summary: This study was conducted to evaluate the efficacy and safety of heat-treated Lactiplantibacillus plantarum LM1004 in improving immune function in adults.
This was a randomized, double-blind, placebo-controlled, single-center clinical trial. Healthy adults aged 19 to 75 years who met the eligibility criteria were enrolled and randomly assigned to receive either the study product or a placebo. Participants in the study group received heat-treated Lactiplantibacillus plantarum LM1004, while participants in the contro...